SPY—QQQ719.02+0.09%BTC/USD—DIA—GLD—TLT79.52+0.08%
Benzinga
Updated: Oct 19, 2026

Benjamin Burnett's Stock Ratings

Wells Fargo Analyst

Benjamin Burnett is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

8.21%

Smart Score

55%

Overall Average Return Percentile

56th

Number of Ratings

100
Buy NowGet Alert
10/14/2026LQDABuy Now
Liquidia
$34.07-3.15%$30 → $33MaintainsEqual-WeightGet Alert
10/02/2026LQDABuy Now
Liquidia
$34.07-11.95%$108 → $30DowngradeOverweight → Equal-WeightGet Alert
09/18/2026XENEBuy Now
Xenon Pharmaceuticals
$35.0882.44%$69 → $64MaintainsOverweightGet Alert
09/03/2026RAREBuy Now
Ultragenyx Pharmaceutical
$15.0719.44%$50 → $18MaintainsOverweightGet Alert
08/20/2026RAREBuy Now
Ultragenyx Pharmaceutical
$15.07205.24%$45 → $46MaintainsOverweightGet Alert
08/13/2026LQDABuy Now
Liquidia
$34.07216.97%$62 → $108MaintainsOverweightGet Alert
08/13/2026PTCTBuy Now
PTC Therapeutics
$61.5377.15%$106 → $109MaintainsOverweightGet Alert
08/13/2026DFTXBuy Now
Definium Therapeutics
$33.00118.18%$68 → $72MaintainsOverweightGet Alert
08/11/2026AXSMBuy Now
Axsome Therapeutics
$155.9964.11%$255 → $256MaintainsOverweightGet Alert
08/07/2026AMPHBuy Now
Amphastar Pharma
$26.14-23.49%$19 → $20MaintainsEqual-WeightGet Alert
08/07/2026PRAXBuy Now
Praxis Precision Medicine
$260.1739.14%$323 → $362MaintainsEqual-WeightGet Alert
08/07/2026INSMBuy Now
Insmed
$95.2977.35%$161 → $169MaintainsOverweightGet Alert
08/06/2026MNKDBuy Now
MannKind
$3.09320.71%$14 → $13MaintainsOverweightGet Alert
08/05/2026RAREBuy Now
Ultragenyx Pharmaceutical
$15.07198.61%$47 → $45MaintainsOverweightGet Alert
08/04/2026KROSBuy Now
Keros Therapeutics
$11.0662.75%$20 → $18MaintainsOverweightGet Alert
07/31/2026PTCTBuy Now
PTC Therapeutics
$61.5372.27%$93 → $106MaintainsOverweightGet Alert
07/30/2026MNKDBuy Now
MannKind
$3.09353.07%$11 → $14MaintainsOverweightGet Alert
07/27/2026HELPBuy Now
Helus Pharma
$10.5052.38% → $16Initiates → OverweightGet Alert
07/27/2026GHRSBuy Now
GH Research
$18.23141.36% → $44Initiates → OverweightGet Alert
07/27/2026DFTXBuy Now
Definium Therapeutics
$33.00106.06% → $68Initiates → OverweightGet Alert
07/27/2026CMPSBuy Now
Compass Pathways
$11.0817.35% → $13Initiates → Equal-WeightGet Alert
07/20/2026PTCTBuy Now
PTC Therapeutics
$61.5351.15%$95 → $93MaintainsOverweightGet Alert
07/15/2026INSMBuy Now
Insmed
$95.2968.96%$160 → $161MaintainsOverweightGet Alert
06/29/2026ALKSBuy Now
Alkermes
$42.9751.27%$44 → $65MaintainsOverweightGet Alert
05/20/2026WVEBuy Now
WAVE Life Sciences
$3.19338.87%$13 → $14MaintainsOverweightGet Alert
05/14/2026AMPHBuy Now
Amphastar Pharma
$26.14-27.31%$30 → $19DowngradeOverweight → Equal-WeightGet Alert
05/12/2026LQDABuy Now
Liquidia
$34.0781.97%$51 → $62MaintainsOverweightGet Alert
05/08/2026PTCTBuy Now
PTC Therapeutics
$61.5354.4%$86 → $95MaintainsOverweightGet Alert
05/08/2026INSMBuy Now
Insmed
$95.2967.91%$177 → $160MaintainsOverweightGet Alert
05/07/2026MNKDBuy Now
MannKind
$3.09223.62%$8 → $10MaintainsOverweightGet Alert
05/07/2026UTHRBuy Now
United Therapeutics
$543.1535.87%$575 → $738UpgradeEqual-Weight → OverweightGet Alert
05/06/2026RAREBuy Now
Ultragenyx Pharmaceutical
$15.07211.88%$45 → $47MaintainsOverweightGet Alert
05/06/2026ALKSBuy Now
Alkermes
$42.972.4%$43 → $44MaintainsOverweightGet Alert
05/05/2026AXSMBuy Now
Axsome Therapeutics
$155.9963.47%$225 → $255MaintainsOverweightGet Alert
04/28/2026MNKDBuy Now
MannKind
$3.09158.9%$7 → $8MaintainsOverweightGet Alert
04/20/2026CNTABuy Now
Centessa Pharmaceuticals
——$35 → $42DowngradeOverweight → Equal-WeightGet Alert
03/31/2026UTHRBuy Now
United Therapeutics
$543.155.86%$486 → $575MaintainsEqual-WeightGet Alert
03/27/2026WVEBuy Now
WAVE Life Sciences
$3.19307.52%$27 → $13MaintainsOverweightGet Alert
03/24/2026INSMBuy Now
Insmed
$95.2985.75%$175 → $177MaintainsOverweightGet Alert
03/23/2026LQDABuy Now
Liquidia
$34.0749.68%$44 → $51MaintainsOverweightGet Alert
03/23/2026UTHRBuy Now
United Therapeutics
$543.15-10.52%$466 → $486MaintainsEqual-WeightGet Alert
03/23/2026INSMBuy Now
Insmed
$95.2983.65%$208 → $175MaintainsOverweightGet Alert
03/11/2026RAPPBuy Now
Rapport Therapeutics
$28.9658.84%$43 → $46MaintainsOverweightGet Alert
03/10/2026XENEBuy Now
Xenon Pharmaceuticals
$35.0893.84%$49 → $68MaintainsOverweightGet Alert
03/06/2026LQDABuy Now
Liquidia
$34.0729.14%$31 → $44MaintainsOverweightGet Alert
03/05/2026KROSBuy Now
Keros Therapeutics
$11.0680.83%$23 → $20MaintainsOverweightGet Alert
02/27/2026AMPHBuy Now
Amphastar Pharma
$26.1414.77%$34 → $30MaintainsOverweightGet Alert
02/27/2026XENEBuy Now
Xenon Pharmaceuticals
$35.0839.68%$48 → $49MaintainsOverweightGet Alert
02/27/2026MNKDBuy Now
MannKind
$3.09126.54%$8 → $7MaintainsOverweightGet Alert
02/26/2026UTHRBuy Now
United Therapeutics
$543.15-14.2%$423 → $466MaintainsEqual-WeightGet Alert
02/26/2026ALKSBuy Now
Alkermes
$42.970.07%$37 → $43MaintainsOverweightGet Alert
02/24/2026AXSMBuy Now
Axsome Therapeutics
$155.9929.5%$193 → $202MaintainsOverweightGet Alert
02/20/2026PRAXBuy Now
Praxis Precision Medicine
$260.1717.23%$282 → $305MaintainsEqual-WeightGet Alert
02/20/2026PTCTBuy Now
PTC Therapeutics
$61.5339.77%$93 → $86MaintainsOverweightGet Alert
02/20/2026INSMBuy Now
Insmed
$95.29118.28%$234 → $208MaintainsOverweightGet Alert
02/12/2026WVEBuy Now
WAVE Life Sciences
$3.19746.39%$29 → $27MaintainsOverweightGet Alert
02/02/2026RAPPBuy Now
Rapport Therapeutics
$28.9648.48% → $43Initiates → OverweightGet Alert
02/02/2026PRAXBuy Now
Praxis Precision Medicine
$260.178.39% → $282Initiates → Equal-WeightGet Alert
01/13/2026AXSMBuy Now
Axsome Therapeutics
$155.9923.73%$157 → $193MaintainsOverweightGet Alert
12/30/2025RAREBuy Now
Ultragenyx Pharmaceutical
$15.07198.61%$65 → $45MaintainsOverweightGet Alert
12/18/2025SVRABuy Now
Savara
$4.6792.72%$7 → $9MaintainsOverweightGet Alert
12/16/2025INSMBuy Now
Insmed
$95.29145.57%$217 → $234MaintainsOverweightGet Alert
12/11/2025XENEBuy Now
Xenon Pharmaceuticals
$35.0836.83%$44 → $48MaintainsOverweightGet Alert
12/09/2025WVEBuy Now
WAVE Life Sciences
$3.19809.09%$16 → $29MaintainsOverweightGet Alert
11/20/2025AVDLBuy Now
Avadel Pharmaceuticals
——$20 → $22.5MaintainsEqual-WeightGet Alert
11/13/2025CNTABuy Now
Centessa Pharmaceuticals
——$30 → $35MaintainsOverweightGet Alert
11/13/2025ALKSBuy Now
Alkermes
$42.97-13.89%$42 → $37MaintainsOverweightGet Alert
11/11/2025WVEBuy Now
WAVE Life Sciences
$3.19401.57%$18 → $16MaintainsOverweightGet Alert
11/11/2025MNKDBuy Now
MannKind
$3.09158.9%$10 → $8MaintainsOverweightGet Alert
11/11/2025KROSBuy Now
Keros Therapeutics
$11.06107.96%$26 → $23MaintainsOverweightGet Alert
11/07/2025CNTABuy Now
Centessa Pharmaceuticals
——$31 → $30MaintainsOverweightGet Alert
11/07/2025AVDLBuy Now
Avadel Pharmaceuticals
——$16 → $20MaintainsEqual-WeightGet Alert
11/05/2025PTCTBuy Now
PTC Therapeutics
$61.5351.15%$73 → $93MaintainsOverweightGet Alert
11/04/2025XENEBuy Now
Xenon Pharmaceuticals
$35.0825.43%$48 → $44MaintainsOverweightGet Alert
11/04/2025AXSMBuy Now
Axsome Therapeutics
$155.990.65%$163 → $157MaintainsOverweightGet Alert
10/30/2025UTHRBuy Now
United Therapeutics
$543.15-22.12%$414 → $423MaintainsEqual-WeightGet Alert
10/29/2025ALKSBuy Now
Alkermes
$42.97-2.26%$44 → $42MaintainsOverweightGet Alert
09/03/2025XENEBuy Now
Xenon Pharmaceuticals
$35.0836.83% → $48AssumesOverweight → OverweightGet Alert
09/03/2025AXSMBuy Now
Axsome Therapeutics
$155.994.49% → $163Assumes → OverweightGet Alert
09/03/2025CNTABuy Now
Centessa Pharmaceuticals
—— → $31Initiates → OverweightGet Alert
09/03/2025AVDLBuy Now
Avadel Pharmaceuticals
—— → $16Initiates → Equal-WeightGet Alert
09/03/2025ALKSBuy Now
Alkermes
$42.972.4% → $44Initiates → OverweightGet Alert
04/01/2025RVMDBuy Now
Revolution Medicines
$181.36-64.71%$78 → $64MaintainsBuyGet Alert
03/06/2025FATEBuy Now
Fate Therapeutics
$1.8661.29%$5 → $3MaintainsHoldGet Alert
02/27/2025RVMDBuy Now
Revolution Medicines
$181.36-56.99%$80 → $78MaintainsBuyGet Alert
02/13/2025CRSPBuy Now
CRISPR Therapeutics
$49.96-1.92%$53 → $49MaintainsHoldGet Alert
01/24/2025IRONBuy Now
Disc Medicine
$77.8020.82%$90 → $94MaintainsBuyGet Alert
12/13/2024RPTXBuy Now
Repare Therapeutics
——$9 → $4MaintainsBuyGet Alert
12/10/2024IRONBuy Now
Disc Medicine
$77.8015.68%$79 → $90MaintainsBuyGet Alert
10/18/2024ACLXBuy Now
Arcellx
——$83 → $122MaintainsBuyGet Alert
09/11/2024BEAMBuy Now
Beam Therapeutics
$24.03187.14%$66 → $69MaintainsBuyGet Alert
09/10/2024IDYABuy Now
IDEAYA Biosciences
$33.81101.12%$63 → $68MaintainsBuyGet Alert
08/06/2024CRSPBuy Now
CRISPR Therapeutics
$49.9618.09%$60 → $59MaintainsHoldGet Alert
07/08/2024IDYABuy Now
IDEAYA Biosciences
$33.8186.34%$63 → $63MaintainsBuyGet Alert
06/04/2024IDYABuy Now
IDEAYA Biosciences
$33.8186.34%$55 → $63MaintainsBuyGet Alert
06/03/2024PGENBuy Now
Precigen
$6.6749.93%$7 → $10MaintainsBuyGet Alert
05/15/2024PGENBuy Now
Precigen
$6.674.95%$7 → $7MaintainsBuyGet Alert
05/15/2024ACLXBuy Now
Arcellx
——$82 → $83MaintainsBuyGet Alert
05/14/2024ALLOBuy Now
Allogene Therapeutics
$1.31251.68%$4.4 → $4.6MaintainsHoldGet Alert
04/08/2024IRONBuy Now
Disc Medicine
$77.80-6.17%$71 → $73MaintainsBuyGet Alert

Recent Analyst Stock Rating News

Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results
Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results
Axsome Therapeutics (NASDAQ:AXSM) reported Q2 losses of 99 cents per share and sales of $218.4 million, missing analyst estimates. Analysts have mixed price targets for the stock.
This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Analysts downgraded DOCS, MWH, WHR, AMPH, and WIX and lowered price targets. See how analysts view these stocks. Considering WHR stock? See analyst opinions.
These Analysts Boost Their Forecasts On Liquidia After Upbeat Q1 Results
These Analysts Boost Their Forecasts On Liquidia After Upbeat Q1 Results
Liquidia Corp (LQDA) reported better-than-expected Q1 results, with earnings of 52 cents per share and sales of $132.865 million. Analysts raised price targets on LQDA stock.
WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
AutoZone To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Tuesday
AutoZone To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Tuesday
Analysts change outlook on top names: Truist cut KFY price target, Oppenheimer raised AZO target, B. Riley slashed YEXT target, Stifel cut MTN target, RBC raised KNTK target, Truist cut MAA target, Wells Fargo raised XENE target, Citigroup raised HIMS target.
Liquidia Analysts Boost Their Forecasts After Q4 Earnings
Liquidia Analysts Boost Their Forecasts After Q4 Earnings
Liquidia Corp (LQDA) reported mixed Q4 results, with earnings missing estimates but sales beating expectations. Analysts have mixed opinions on stock.
These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings
These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings
Beyond The Numbers: 11 Analysts Discuss Axsome Therapeutics Stock
Beyond The Numbers: 11 Analysts Discuss Axsome Therapeutics Stock
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved